Change history 11 December 2024 “An overview of approaches to estimating seasonal influenza vaccine effectiveness (VE)” should has been processed as the section heading References Shaw AR. Universal influenza vaccine: the holy grail? Expert Rev Vaccines. 2012;11(8):923–7. Article CAS PubMed ...
The 2023–2024 US influenza season was characterized by a predominance of A(H1N1)pdm09 virus circulation with cocirculation of A(H3N2) and B/Victoria viruses. We estimated vaccine effectiveness (VE) in the United States against mild-to-moderate medically attended influenza illness in the 2023–...
Influenza vaccine effectiveness against hospitalizations associated with influenza A(H3N2) in Hong Kong children aged 9 months to 17 years, June-November 2023 Vaccine, 42 (2024), pp. 1878-1882 View PDFView articleView in ScopusGoogle Scholar [8] L.A. Grohskopf, L.H. Blanton, J.M. Ferdinan...
The global influenza vaccine market size was valued at USD 7.97 billion in 2023 and is projected to grow from USD 8.55 billion in 2024 to USD 17.77 billion by 2032, exhibiting a CAGR of 9.6% during the forecast (2024-2032). North America accounted for a market value of USD 4.28 billion ...
Conclusions: This is the first study to demonstrate influenza vaccine effectiveness in children after the relaxation of strict COVID-19 measures in Japan (2023/2024). We recommend the current inactivated vaccine for preventing both influenza A and B in children, with consideration for the potential...
The objective of this study was to provide an estimate of influenza vaccine effectiveness (VE) against influenza-associated hospitalization in children in Hong Kong during an A(H3N2) epidemic in June-November 2023. Access through your organization Check access to the full text by signing in ...
Received a total of 2 or more doses of any seasonal influenza vaccine ≥4 weeks apart before July 1, 2024: Administer a single 0.5 mL dose of Fluarix or Flulaval.Infants and Children 6 through 35 Months of Age (Fluzone) IM For infants and children 6 through 35 months of age, 0.25 ...
However, viral resistance to these agents has been observed, thereby reducing their effectiveness. A newer category of drugs, the neuraminidase inhibitors, which includes oseltamivir (Tamiflu) and zanamivir (Relenza), was introduced in the late 1990s; these drugs inhibit both the influenza A and B...
Order 2024-25 doses today Recommended as an option by the ACIP and AAP13,14 *There are no head-to-head clinical studies comparing LAIV4 and IIV. Results are descriptive only. †LAIV4 and IIV vaccine effectiveness (VE) data overlapped for all strains, demonstrating the general VE comparabil...
Seasonal influenza vaccine effectiveness, 2004–2018 https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates (CDC, 2019). Erbelding, E. J. et al. A universal influenza vaccine: the strategic plan for the national institute of allergy and infectious diseases. J. Infect. Dis. 218, 347...